Ledger.Open graph →
SEC Form D · Amendment · filed September 2, 2010

TALIGEN THERAPEUTICS INC

Offering
$65.0M
Sold
$36.0M
Exemption
—
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

People & firms on this filing (10)

Michael M. Carroll · Richmond, VAExec · DirectorNicholas Galakatos · Cambridge, MADirectorTimothy C. Mills · Cambridge, MADirectorEd Hurwitz · Cambridge, MADirectorJohn Maraganore · Cambridge, MADirectorRobert R. Wotzcak · Gladstone, NJExec · DirectorWilliam B. Burton · Toronto, Ontario, CanadaDirectorGary E. German · Toronto, Ontario, CanadaDirectorMoustapha Niasse · Toronto, Ontario, CanadaDirectorJohn Maraganore · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗